dabigatran has been researched along with Postoperative Complications in 119 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (10.08) | 29.6817 |
| 2010's | 97 (81.51) | 24.3611 |
| 2020's | 10 (8.40) | 2.80 |
| Authors | Studies |
|---|---|
| Gromov, K; Jensen, TB; Jimenez-Solem, E; Olesen, JB; Overgaard, S; Petersen, J; Schelde, AB | 1 |
| Álvarez-García, J; de Nadal, M; Popova, E | 1 |
| Elder, M; Hung, YC; Morris, A | 1 |
| Aiki, T; Aoyama, D; Fukuoka, Y; Hasegawa, K; Ikeda, H; Ishida, K; Ishikawa, E; Kaseno, K; Matsui, A; Miyahara, K; Miyazaki, S; Morishita, T; Mukai, M; Shiomi, Y; Tada, H; Tama, N; Uzui, H; Yamaguchi, J | 1 |
| Ageno, W; Casella, IB; Chee, KH; Desch, M; Donado, E; Goldhaber, SZ; Reilly, PA; Schellong, S; Schulman, S; Singer, DE; Tang, W; Voccia, I | 1 |
| Douketis, J; Kaplovitch, E; Shaw, JR | 1 |
| Doyama, H; Fujishiro, M; Fujita, T; Hasatani, K; Hatta, W; Hiasa, Y; Hikichi, T; Igarashi, K; Iguchi, M; Inoue, T; Kawaguchi, K; Kitamura, K; Kuribayashi, S; Mikami, T; Morita, Y; Nishida, T; Nishikawa, J; Oda, I; Sumiyama, K; Sumiyoshi, T; Tomida, H; Tsuji, Y; Uraoka, T; Yada, T; Yamamoto, K; Yanagitani, A; Yoshio, T | 1 |
| Goya, M; Hirao, K; Kawabata, M; Maeda, S; Sasano, T; Takahashi, Y; Yagishita, A | 1 |
| Qu, R; Song, R; Wang, Y; Zhang, A; Zhou, D | 1 |
| Brouwer, RW; Gerritsma-Bleeker, CL; Segers, M; van der Veen, L; van Hulst, M; van Raay, JJ; Veeger, NJ | 1 |
| Chan, FK; Guo, CL; Lam, KL; Lau, LH; Mak, JW; Ng, SC; Wong, GL; Wong, SH; Yip, TC | 1 |
| Jeon, SH; Kim, MS; Kwon, GH | 1 |
| Biccard, BM; Devereaux, PJ; Duceppe, E; Franzosi, MG; Lamy, A; Meyhoff, CS; Mian, R; Parlow, J; Srinathan, SK; Szczeklik, W; Tong, W; Vincent, J; Xavier, D | 1 |
| Biss, B; Brouwer, MA; Calkins, H; Gerstenfeld, EP; Grimaldi, M; Guiver, K; Hohnloser, SH; Nordaby, M; Okumura, K; Schilling, R; Serota, H; Verma, A; Willems, S | 1 |
| Fink, B; Mayer, A; Schuster, P | 1 |
| Abugattas de Torres, JP; Brugada, P; Chierchia, GB; Choudhury, R; Coutino-Moreno, HE; de Asmundis, C; De Regibus, V; Iacopino, S; Longobardi, M; Mugnai, G; Storti, C; Stroker, E; Takarada, K | 1 |
| Blennerhassett, R; Favaloro, EJ; Pasalic, L | 1 |
| Chu, XC; Gao, JH; Ning, B; Wang, LL; Zhao, CX | 1 |
| Antia, C; Gloster, H; Hone, N | 1 |
| Anderson, JM; Arnold, DM; Bates, SM; Blostein, M; Caprini, JA; Carrier, M; Clark, NP; Coppens, M; Dentali, F; Douketis, JD; Duncan, J; Gross, PL; Kassis, J; Kowalski, S; Le Gal, G; Le Templier, G; Lee, AY; Li, N; MacKay, E; Schulman, S; Shah, V; Shivakumar, S; Solymoss, S; Spencer, FA; Spyropoulos, AC; Syed, S; Tafur, AJ; Thiele, T; Vanassche, T; Wu, C; Yeo, E | 1 |
| Franco Moreno, AI; García Navarro, MJ; Martín Díaz, RM | 1 |
| Bangdiwala, SI; Berwanger, O; Biccard, BM; Botto, F; Chaudhry, NK; Connolly, SJ; de Nadal, M; Devereaux, PJ; Duceppe, E; Eikelboom, JW; Franzosi, MG; Guyatt, G; Kearon, C; Magloire, P; Mayosi, B; Meyhoff, CS; Neary, J; Parlow, J; Pettit, S; Popova, E; Rao, M; Rodseth, R; Sessler, DI; Sharma, M; Srinathan, SK; Szczeklik, W; Tandon, V; Villar, JC; Vincent, J; Xavier, D; Yusuf, S | 1 |
| Alviz, I; Avendano, R; Cerna, L; Cerrud-Rodriguez, RC; Di Biase, L; Diaz, JC; Grupposo, V; Kirchhof, P; Kumar, S; Michaud, GF; Natale, A; Romero, J; Taveras, J | 1 |
| Bawa, H; Dirschl, DR; Luu, HH; Weick, JW | 1 |
| Chabot, JA; Dwyer, FA; Jackson, TL; Kluger, MD; Morgan, JA; Rashid, MF; Schrope, BA | 1 |
| Ayala-Paredes, F; Becker, G; Birnie, DH; Connolly, SJ; Coutu, B; Eikelboom, J; Essebag, V; Healey, JS; Kalfon, E; Lellouche, N; Nery, PB; Philippon, F; Sandhu, RK; Sapp, J; Sumner, GL; Verma, A; Wells, GA | 1 |
| Antropova, IP; Reino, EV; Yushkov, BG | 1 |
| Guijarro Merino, R; Villalobos Sánchez, A | 1 |
| Abi-Saleh, B; Alam, S; Baranowski, B; Bassiouny, M; Borek, PP; Callahan, T; Chung, M; Diab, M; Dresing, T; Hussein, A; Kanj, M; Khoury, M; Lindsay, BD; Martin, DO; Niebauer, M; Rickard, J; Saliba, W; Sengupta, J; Sey, A; Shao, M; Tchou, PJ; Varma, N; Wazni, O | 1 |
| Doppalapudi, H; Gunter, A; Kay, GN; Maddox, W; McElderry, HT; Osorio, J; Plumb, VJ; Yamada, T | 1 |
| Bazargan, A; Douglas, G; McKenzie, JL | 1 |
| Bordeaux, JS; Schmitt, AR; Zender, CA | 1 |
| Ellis, CR; Kaiser, DW; Nagarakanti, R; Streur, MM; Whalen, SP | 1 |
| Amnueypol, M; Calkins, H; Haines, DE; Marchlinski, FE; Mead-Salley, M; Nademanee, K; Saklani, P; Salazar, M; Skanes, AC; Yarmohammadi, H; Zado, E | 1 |
| Douketis, J; Liew, A | 1 |
| Joutsi-Korhonen, L; Lassila, R; Pétas, A; Rannikko, AS; Säily, VM; Taari, K | 1 |
| Chana, F; Llau, JV; Marco, P; Zamorano, JL | 1 |
| Alexander, JH; Atwater, BD; Bahnson, TD; Daubert, JP; Hasselblad, V; Piccini, JP; Steinberg, BA; Washam, JB | 1 |
| Wanat, MA | 1 |
| Brosa, M; Diamantopoulos, A; Folkerts, K; Imberti, D; Monreal, M | 1 |
| Aldin, ES; Greenberg, C; Rachidi, S; Sachs, B; Streiff, M; Zeidan, AM | 1 |
| Dütsch, M; Klauser, W | 1 |
| Baker, R; Herrmann, R; Muhammad, S; Phillips, M; Thom, J; Wood, A | 1 |
| Acket, B; Bagheri, H; Bourrel, R; Lavezzi, O; Molinier, A; Montastruc, JL | 1 |
| Angiolillo, DJ; Capodanno, D | 1 |
| Fredenburgh, JC; Liao, P; Roberts, RS; Weitz, JI; Yau, JW | 1 |
| Iung, B; Vahanian, A | 1 |
| Hess, T; Konturek, P | 1 |
| Engel, G; Kong, MH; Mead, RH; Patrawala, RA; Winkle, RA | 1 |
| Cui, J; Li, Z; Liu, C; Wu, B | 1 |
| Hirao, H; Suenari, K; Ueda, H | 1 |
| Cantillon, D; Coleman, CM; Kanj, M; Khalaf, S; Mould, S; Saliba, W; Wazni, O | 1 |
| Cattaneo, M; Lussana, F; Squizzato, A | 1 |
| Altıntaş, F; Önal, A; Özler, T; Uluçay, Ç | 1 |
| Fosbøl, E; Gislason, G; Jensen, P; Jensen, T; Koeber, L; Olesen, J; Thorsberger, M; Torp-Pedersen, C; Wahlsten, L; Weeke, P | 1 |
| Heeger, CH; Kuck, KH; Lemes, C; Lin, T; Mathew, S; Metzner, A; Ouyang, F; Plesman, J; Rillig, A; Tilz, RR; Wissner, E; Wohlmuth, P | 1 |
| Dechering, DG; Eckardt, L; Foraita, P; Güner, F; Kochhäuser, S; Lange, PS; Leitz, P; Mönnig, G; Pott, C; Wasmer, K; Zellerhoff, S | 1 |
| Aguilar-Salvatierra, A; Calvo-Guirado, JL; de Carlos, F; Delgado-Ruiz, RA; Fernández-Cejas, E; Gómez-Moreno, G | 1 |
| Dahmen, A; Gorr, E; Hoppe, C; Horlitz, M; Keskin, K; Koektuerk, B; Schoett, M; Turan, CH; Turan, RG; Yang, A; Yorgun, H | 1 |
| Funabashi, N; Goto, E; Kaseno, K; Kumagai, K; Minami, K; Naito, S; Nakamura, K; Oshima, S; Sasaki, T; Senga, M; Shimizu, S; Suzuki, N; Take, Y; Yamaguchi, Y; Yano, T | 1 |
| Feng, Y; Li, PJ; Liang, ZA; Liu, GJ; Wang, T; Xiao, J; Yang, Q | 1 |
| Babhulkar, S; Clemens, A; Dadi, A; Iyer, R; Kamath, S; Malhotra, R; Mody, B; Mutha, S; Reddy, G; Sanjib, KB; Shah, V; Shetty, N; Tapasvi, S; Wadhwa, M | 1 |
| Aoyagi, H; Asano, M; Hirao, K; Kawaguchi, N; Kurabayashi, M; Nakamura, T; Okishige, K; Sasano, T; Shimura, T; Suzuki, H; Yamashita, M; Yamauchi, Y | 1 |
| Pasechnik, IN | 1 |
| Akhtyamov, IF; Shigaev, ES; Ziatdinov, BG | 1 |
| Davies, RA; Orr, Y; Perera, NK | 1 |
| Chaiyakunapruk, N; Chongmelaxme, B; Kotirum, S | 1 |
| Ferrandis, R; Llau, JV; López Forte, C; Sapena, ML | 1 |
| Bounameaux, H | 1 |
| Crowther, MA; Lepic, K | 1 |
| Borris, LC | 1 |
| Blanc, Q; Duntze, J; Hanf, W; Hida, H; Reynaud, C | 1 |
| Brenkel, IJ; Clemens, A; Dolan, G; Noack, H; Plumb, JM; Robinson, PA; Roskell, NS; Wolowacz, SE | 1 |
| Verma, AK | 1 |
| Caglayan, E; Er, F; Erdmann, E; Gassanov, N | 1 |
| Margieva, AV; Omel'ianovskiĭ, VV; Tsfasman, FM; Zagorodniĭ, NV | 1 |
| Asencio, J; Garcia-Ortega, P | 1 |
| Alban, S; Völler, H; Westermann, D | 1 |
| Clemens, A; Monz, BU; Plumb, JM | 1 |
| Crowther, M; Lepic, K | 1 |
| Dahl, OE; Huisman, MV; Quinlan, DJ; Schulman, S | 1 |
| Kwok, CS; Loke, YK | 1 |
| Dahl, OE; Eriksson, BI; Friedman, RJ; Hantel, S; Hermansson, K; Huo, MH; Kurth, AA; Schnee, JM | 1 |
| Meddahi, S; Samama, MM | 1 |
| Ageno, W; Prandoni, P | 1 |
| Diamantopoulos, A; Lees, M; Lereun, C; Rasul, F; Sengupta, N; Wells, P | 1 |
| Samama, CM | 1 |
| Cerbone, AM; Coppola, A; Franchini, M; Ruosi, C; Tufano, A | 1 |
| Alonso de Leciñana, M; Aparicio, M; Buisan, J; García-Caldentey, J; Guillán, M; Masjuan, J; Matute, MC | 1 |
| Ajzenberg, N; Dumont, B; Faille, D | 1 |
| Qureshi, AI; Siddiqui, FM; Watanabe, M | 1 |
| Astell, H; Stewart, RA; White, HD; Young, L | 1 |
| Galanis, T; Kraft, WK; Merli, GJ | 1 |
| Heidinger, K; Kemkes-Matthes, B | 1 |
| Combe, S; Conard, J; Flaujac, C; Horellou, MH; Samamaa, MM | 1 |
| Clemens, A; Härtter, S; Reilly, PA; Stangier, J; Yamamura, N | 1 |
| Migliaccio-Walle, K; Rublee, D; Simon, TA | 1 |
| Alpert, JS | 1 |
| Barrellier, MT; Dutheil, JJ; Gouzy, S; Lebel, B; Malherbe, M; Parienti, JJ; Vielpeau, C | 1 |
| Cohen, A; Drost, P; Marchant, N; Mitchell, S; Orme, M; Rublee, D; Simon, TA; Sutton, A | 1 |
| Brouwers, JR; Kappelhoff, BS; Postma, MJ; van Hulst, M | 1 |
| Burness, CB; McKeage, K | 1 |
| Avezum, A; Connolly, SJ; Douketis, J; Eikelboom, J; Ezekowitz, M; Healey, JS; Heidbuchel, H; Heidbuchle, H; Oldgren, J; Reilly, P; Themeles, E; Wallentin, L; Yang, S; Yusuf, S | 1 |
| Barsness, GW; Caprini, J; Clemens, A; Eriksson, BI; Feuring, M; Hantel, S; Schnee, J; Smith, JJ | 1 |
| Fugate, JE; Lanzino, G; McBane, RD; Rabinstein, AA | 1 |
| Barry, M; McCullagh, L | 1 |
| Clemens, A; Dahl, OE; Eriksson, BI; Feuring, M; Friedman, RJ; Hantel, S; Huo, M; Noack, H | 1 |
| Johns, G; Kauffman, C; Kusumoto, F; Prussak, K; Snipelisky, D; Venkatachalam, K | 1 |
| Aalbers, J | 1 |
| Lazo-Langner, A; Sun, D | 1 |
| Jackiewicz, A; Krzemiński, M; Mrozik, D | 1 |
| Ahnfelt, L; Bravo, ML; Büller, HR; Dahl, OE; Eriksson, BI; Hettiarachchi, R; Kälebo, P; Piovella, F; Reilly, P; Rosencher, N; Stangier, J | 1 |
| Liesenfeld, KH; Schäfer, HG; Stangier, J; Tillmann, C; Trocóniz, IF | 1 |
| Büller, HR; Christiansen, AV; Dahl, OE; Eriksson, BI; Frostick, SP; Hantel, S; Hettiarachchi, R; Kälebo, P; Kurth, AA; Rosencher, N; Schnee, J; van Dijk, CN | 1 |
| Norrie, J | 1 |
| Büller, HR; Dahl, OE; Eriksson, BI; Frostick, SP; Hantel, S; Hettiarachchi, R; Kurth, AA; Prins, MH; Rosencher, N; Schnee, J; van Dijk, CN | 1 |
| Martins, HS; Scalabrini-Neto, A; Velasco, IT | 1 |
| Klapper, U; Messer, I; Neumann, K; Röleke, D; Seidel, U; Werner, A; Wilke, T | 1 |
34 review(s) available for dabigatran and Postoperative Complications
| Article | Year |
|---|---|
Myocardial Injury After Noncardiac Surgery. Could Dabigatran Be a First Step in Its Management?
Topics: Antithrombins; Dabigatran; Humans; Myocardial Ischemia; Postoperative Complications; Surgical Procedures, Operative | 2019 |
Periprocedural Management of Oral Anticoagulation.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Perioperative Care; Postoperative Complications; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Surgical Procedures, Operative; Warfarin | 2020 |
Novel (Oral) Anticoagulant Challenges in Surgery.
Topics: Administration, Oral; Anticoagulants; Dabigatran; Humans; Perioperative Period; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Thromboembolism | 2017 |
Effects of different anticoagulant drugs on the prevention of complications in patients after arthroplasty: A network meta-analysis.
Topics: Anticoagulants; Arthroplasty; Azetidines; Benzylamines; Dabigatran; Enoxaparin; Heparin; Heparin, Low-Molecular-Weight; Humans; Network Meta-Analysis; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Treatment Outcome; Venous Thromboembolism; Warfarin | 2017 |
Direct oral anticoagulants: An update.
Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Secondary Prevention; Stroke; Thiazoles; Venous Thromboembolism; Withholding Treatment | 2018 |
Uninterrupted direct oral anticoagulants vs. uninterrupted vitamin K antagonists during catheter ablation of non-valvular atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Catheter Ablation; Cerebral Infarction; Dabigatran; Drug Administration Schedule; Factor Xa Inhibitors; Hemorrhage; Humans; Postoperative Complications; Postoperative Hemorrhage; Risk Factors; Rivaroxaban; Severity of Illness Index; Thromboembolism; Warfarin | 2018 |
[Prophylaxis of venous thromboembolism in orthopedic surgery. Role of the new anticoagulants].
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2012 |
Perioperative management of anticoagulation in elective surgery.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Cardiovascular Diseases; Clopidogrel; Dabigatran; Elective Surgical Procedures; Humans; Perioperative Care; Platelet Aggregation Inhibitors; Postoperative Complications; Risk Assessment; Thromboembolism; Ticlopidine; Withholding Treatment | 2013 |
[New clinical perspectives in the management of oral direct anticoagulant agents].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Elective Surgical Procedures; Emergencies; Factor Xa Inhibitors; Hemorrhage; Humans; Kidney Diseases; Morpholines; Orthopedic Procedures; Postoperative Complications; Premedication; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Risk; Rivaroxaban; Thiophenes; Thrombophilia; Vitamin K | 2014 |
Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Comorbidity; Dabigatran; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Observational Studies as Topic; Postoperative Complications; Premedication; Risk Factors; Thromboembolism; Treatment Outcome | 2013 |
Novel oral anticoagulants: a review of new agents.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Postoperative Complications; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis | 2013 |
The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery.
Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2013 |
Practical management of new oral anticoagulants after total hip or total knee arthroplasty.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Blood Coagulation Tests; Clinical Trials, Phase III as Topic; Contraindications; Dabigatran; Drug Administration Schedule; Drug Interactions; Drug Monitoring; Hematoma, Epidural, Spinal; Humans; Morpholines; Platelet Aggregation Inhibitors; Postoperative Complications; Postoperative Hemorrhage; Postoperative Nausea and Vomiting; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2013 |
Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.
Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Morpholines; Percutaneous Coronary Intervention; Piperazines; Platelet Aggregation Inhibitors; Postoperative Complications; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thrombosis; Ticagrelor | 2014 |
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Embolism; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K; Warfarin | 2014 |
A systematic review and adjusted indirect comparison of oral anticoagulants.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heparin, Low-Molecular-Weight; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2014 |
Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Brain Ischemia; Clinical Trials, Phase III as Topic; Dabigatran; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Postoperative Complications; Postoperative Hemorrhage; Prothrombin; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Treatment Outcome | 2015 |
Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Causality; Comorbidity; Dabigatran; Female; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thromboembolism; Treatment Outcome; Vitamin K | 2016 |
[The use of new oral anticoagulants in surgery. Part 1].
Topics: Anticoagulants; Dabigatran; Humans; Postoperative Complications; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Surgical Procedures, Operative | 2016 |
Do novel anticoagulant agents increase the risk of perioperative complications during implantable cardiac rhythm device insertion?
Topics: Aged, 80 and over; Anticoagulants; Cardiac Surgical Procedures; Dabigatran; Defibrillators, Implantable; Humans; Intraoperative Complications; Male; Pacemaker, Artificial; Postoperative Complications; Rivaroxaban; Thromboembolism; Warfarin | 2017 |
[Anaesthesia and thromboembolic disease].
Topics: Acenocoumarol; Administration, Oral; Anesthesia, Conduction; Anticoagulants; Benzimidazoles; Clinical Protocols; Dabigatran; Early Ambulation; Fibrinolytic Agents; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Polysaccharides; Postoperative Complications; Pyridines; Risk Factors; Rivaroxaban; Safety; Surgical Procedures, Operative; Thiophenes; Venous Thromboembolism; Venous Thrombosis | 2008 |
A logical approach to surgical thromboprophylaxis.
Topics: Benzimidazoles; Dabigatran; Humans; Morpholines; Postoperative Complications; Premedication; Pyridines; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2009 |
[Dabigatran: a new therapeutic option for therapy and prophylaxis of thromboembolic diseases?].
Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement; Benzimidazoles; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Drug Approval; Half-Life; Humans; Metabolic Clearance Rate; Multicenter Studies as Topic; Postoperative Complications; Prodrugs; Pyridines; Randomized Controlled Trials as Topic; Thrombin; Venous Thromboembolism | 2010 |
[New oral anticoagulants: better than vitamin K antagonists?].
Topics: Anticoagulants; Antithrombin Proteins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis; Vitamin K | 2010 |
New anticoagulants for the prevention of thromboembolism.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2010 |
Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison.
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis | 2011 |
New anticoagulants: pharmacology and clinical studies.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Biological Availability; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Postoperative Complications; Prothrombin; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2011 |
Preventing postsurgical venous thromboembolism: pharmacological approaches.
Topics: Aged; Anticoagulants; Antithrombins; Arthroscopy; Bariatric Surgery; Benzimidazoles; Blood Coagulation Disorders, Inherited; Dabigatran; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Hip Fractures; Humans; Kidney; Knee; Laparoscopy; Morpholines; Neoplasms; Orthopedic Procedures; Polysaccharides; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Thrombophilia; Venous Thromboembolism | 2011 |
[New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Drug Approval; Drug Monitoring; Factor Xa Inhibitors; Fibrinolytic Agents; Forecasting; France; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Thrombin; Thromboembolism; Thrombophilia; Venous Thromboembolism | 2011 |
Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient.
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Morpholines; Neurosurgical Procedures; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stockings, Compression; Surgical Procedures, Operative; Thiophenes; Urologic Surgical Procedures; Venous Thrombosis | 2011 |
[New anticoagulants. Characteristics, monitoring and management of bleeding].
Topics: Administration, Oral; Antithrombins; Arthroplasty, Replacement, Hip; Atrial Fibrillation; Benzimidazoles; Blood Coagulation Tests; Critical Care; Dabigatran; Drug Approval; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Heparin; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; Thrombophilia; Vitamin K | 2011 |
The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: systematic review and network meta-analysis.
Topics: Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Female; Hemorrhage; Humans; Male; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2012 |
Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Postoperative Complications; Pyridines; Randomized Controlled Trials as Topic; Venous Thromboembolism | 2012 |
Dabigatran: a primer for neurosurgeons.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Cerebral Hemorrhage; Dabigatran; Humans; Neurosurgery; Perioperative Care; Postoperative Complications | 2013 |
19 trial(s) available for dabigatran and Postoperative Complications
| Article | Year |
|---|---|
Feasibility of Uninterrupted Direct Oral Anticoagulants with Temporary Switching to Dabigatran ("Dabigatran Bridge") for Catheter Ablation of Atrial Fibrillation.
Topics: Administration, Oral; Aged; Antithrombins; Atrial Fibrillation; Catheter Ablation; Clinical Protocols; Dabigatran; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Postoperative Complications; Thromboembolism | 2019 |
Comparison of the efficacy of rivaroxaban and dabigatran etexilate in preventing venous thrombosis after arthroplasty: A protocol of randomized controlled trial.
Topics: Administration, Oral; Antithrombins; Arthroplasty; Dabigatran; Humans; Postoperative Complications; Prospective Studies; Randomized Controlled Trials as Topic; Rivaroxaban; Treatment Outcome; Venous Thrombosis | 2021 |
Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study.
Topics: Activities of Daily Living; Anticoagulants; Arthroplasty, Replacement, Knee; Dabigatran; Female; Humans; Nadroparin; Netherlands; Pilot Projects; Postoperative Care; Postoperative Complications; Quality of Life; Rivaroxaban; Treatment Outcome; Venous Thromboembolism | 2021 |
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Catheter Ablation; Dabigatran; Female; Hemorrhage; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Postoperative Complications; Stroke; Warfarin | 2017 |
The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant Who Need an Elective Surgery or Procedure: Design and Rationale.
Topics: Administration, Oral; Adult; Anticoagulants; Atrial Fibrillation; Canada; Cardiac Surgical Procedures; Cohort Studies; Dabigatran; Female; Hemorrhage; Humans; Male; Perioperative Period; Postoperative Complications; Precision Medicine; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban | 2017 |
Design of a Randomized Placebo-Controlled Trial to Assess Dabigatran and Omeprazole in Patients with Myocardial Injury after Noncardiac Surgery (MANAGE).
Topics: Aged; Cause of Death; Dabigatran; Double-Blind Method; Female; Follow-Up Studies; Humans; Internationality; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Omeprazole; Postoperative Complications; Proportional Hazards Models; Risk Assessment; Surgical Procedures, Operative; Survival Analysis; Treatment Outcome | 2018 |
Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cardiac Pacing, Artificial; Dabigatran; Defibrillators, Implantable; Drug Administration Schedule; Female; Hematoma; Humans; Length of Stay; Male; Middle Aged; Postoperative Complications; Pyrazoles; Pyridones; Reoperation; Rivaroxaban; Thromboembolism | 2018 |
Dabigatran versus warfarin anticoagulation before and after catheter ablation for the treatment of atrial fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Canada; Catheter Ablation; Comorbidity; Dabigatran; Decision Making; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Humans; Postoperative Complications; Premedication; Risk Factors; Thromboembolism; Treatment Outcome; United States; Warfarin | 2013 |
Cost-effectiveness impact of rivaroxaban versus new and existing prophylaxis for the prevention of venous thromboembolism after total hip or knee replacement surgery in France, Italy and Spain.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Cost of Illness; Cost-Benefit Analysis; Dabigatran; Direct Service Costs; Enoxaparin; France; Humans; Italy; Models, Theoretical; Morpholines; Postoperative Complications; Pyridines; Quality of Life; Rivaroxaban; Spain; Thiophenes; Venous Thromboembolism | 2013 |
Comparison of switch-therapy modalities (enoxaparin to rivaroxaban/dabigatran) and enoxaparin monotherapy after hip and knee replacement.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Dabigatran; Enoxaparin; Female; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Rivaroxaban; Ultrasonography, Doppler; Venous Thrombosis | 2015 |
Thromboprophylaxis with dabigatran after total hip arthroplasty in Indian patients: A subanalysis of a double-blind, double-dummy, randomized RE-NOVATE II study.
Topics: Administration, Oral; Aged; Arthroplasty, Replacement, Hip; Confidence Intervals; Dabigatran; Double-Blind Method; Enoxaparin; Female; Follow-Up Studies; Humans; Incidence; India; Injections, Subcutaneous; Male; Middle Aged; Odds Ratio; Postoperative Complications; Primary Prevention; Prospective Studies; Risk Assessment; Treatment Outcome; Venous Thromboembolism | 2017 |
Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Follow-Up Studies; Hemorrhage; Humans; Morpholines; Postoperative Complications; Prospective Studies; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism; Withholding Treatment | 2010 |
Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Benzimidazoles; beta-Alanine; Dabigatran; Double-Blind Method; Enoxaparin; Female; Hemorrhage; Humans; Injections, Subcutaneous; Male; Middle Aged; Postoperative Complications; Survival Analysis; Venous Thromboembolism; Venous Thrombosis | 2011 |
Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Brain Ischemia; Cardiac Pacing, Artificial; Cataract Extraction; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Risk Factors; Stroke; Thromboembolism; Warfarin | 2012 |
Evaluation of the acute coronary syndrome safety profile of dabigatran etexilate in patients undergoing major orthopedic surgery: findings from four Phase 3 trials.
Topics: Acute Coronary Syndrome; Adult; Aged; Anticoagulants; Benzimidazoles; Dabigatran; Drug-Related Side Effects and Adverse Reactions; Humans; Incidence; Internationality; Male; Middle Aged; Orthopedics; Postoperative Complications; Pyridines; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Thrombosis; Treatment Outcome | 2012 |
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Double-Blind Method; Enoxaparin; Female; Humans; Male; Middle Aged; Odds Ratio; Postoperative Complications; Postoperative Period; Pyridines; Regression Analysis; Thrombin; Thromboembolism | 2005 |
Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery.
Topics: Administration, Oral; Aged; Algorithms; Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; Chromatography, Liquid; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Elective Surgical Procedures; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Postoperative Complications; Pyridines; Software; Tablets; Tandem Mass Spectrometry; Venous Thrombosis | 2007 |
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Benzimidazoles; Clinical Enzyme Tests; Dabigatran; Double-Blind Method; Drug Administration Routes; Enoxaparin; Follow-Up Studies; Hemorrhage; Humans; Middle Aged; Postoperative Complications; Prodrugs; Pyridines; Treatment Outcome; Venous Thrombosis | 2007 |
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Double-Blind Method; Enoxaparin; Female; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Pyridines; Thromboembolism; Venous Thrombosis | 2007 |
66 other study(ies) available for dabigatran and Postoperative Complications
| Article | Year |
|---|---|
Thromboembolic and bleeding complications following primary total knee arthroplasty : a Danish nationwide cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antithrombins; Arthroplasty, Replacement, Knee; Dabigatran; Dalteparin; Denmark; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Proportional Hazards Models; Registries; Rivaroxaban; Tinzaparin; Venous Thromboembolism; Young Adult | 2021 |
Anticoagulation and cataract surgery.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Female; Humans; Male; Middle Aged; Phacoemulsification; Postoperative Complications; Postoperative Hemorrhage; Retrospective Studies; Thromboembolism; Warfarin | 2019 |
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study.
Topics: Administration, Oral; Adult; Age Distribution; Aged; Anticoagulants; Asia; Comorbidity; Cross-Sectional Studies; Dabigatran; Diabetes Mellitus; Europe; Factor Xa Inhibitors; Female; Fondaparinux; Heparin; Humans; Hypertension; Latin America; Male; Middle Aged; Middle East; Neoplasms; Postoperative Complications; Practice Patterns, Physicians'; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Wounds and Injuries | 2020 |
Influence of anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection: a multicenter retrospective study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Endoscopic Mucosal Resection; Female; Humans; Japan; Male; Middle Aged; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stomach; Stomach Neoplasms; Thiazoles; Thromboembolism; Warfarin | 2021 |
A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Loss, Surgical; Carotid Artery Diseases; Cerebral Infarction; Dabigatran; Digestive System Surgical Procedures; Elective Surgical Procedures; Embolism; Endoscopy; Factor Xa Inhibitors; Female; Humans; Male; Myocardial Infarction; Orthopedic Procedures; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Thromboembolism; Urologic Surgical Procedures; Vascular Surgical Procedures | 2020 |
Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis.
Topics: Aged; Anticoagulants; Blood Transfusion; Cohort Studies; Colonic Polyps; Colonoscopy; Dabigatran; Factor Xa Inhibitors; Gastrointestinal Hemorrhage; Hong Kong; Humans; Male; Postoperative Complications; Pyrazoles; Pyridones; Retrospective Studies; Risk Assessment; Rivaroxaban; Thromboembolism; Warfarin | 2022 |
Symptomatic bilateral massive pulmonary embolism and proximal and distal deep vein thrombosis following arthroscopic meniscus surgery: A case report.
Topics: Adult; Anticoagulants; Arthroscopy; Dabigatran; Electrocardiography; Femoral Vein; Heparin, Low-Molecular-Weight; Humans; Male; Meniscus; Popliteal Vein; Postoperative Complications; Pulmonary Artery; Pulmonary Embolism; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis | 2021 |
The Cost Implications of Dabigatran in Patients with Myocardial Injury After Non-Cardiac Surgery.
Topics: Canada; Costs and Cost Analysis; Dabigatran; Heart Injuries; Humans; Postoperative Complications; Randomized Controlled Trials as Topic | 2022 |
A comparison of apixaban and dabigatran etexilate for thromboprophylaxis following hip and knee replacement surgery.
Topics: Adult; Aged; Aged, 80 and over; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Osteoarthritis, Hip; Osteoarthritis, Knee; Postoperative Complications; Pyrazoles; Pyridones; Thrombosis; Treatment Outcome | 2017 |
Comparison of the Incidences of Complications After Second-Generation Cryoballoon Ablation of Atrial Fibrillation Using Vitamin K Antagonists Versus Novel Oral Anticoagulants.
Topics: Ablation Techniques; Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Belgium; Cryosurgery; Dabigatran; Dose-Response Relationship, Drug; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Incidence; Intraoperative Period; Italy; Male; Middle Aged; Postoperative Complications; Prognosis; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Survival Rate; Thiazoles; Time Factors; Vitamin K | 2017 |
Perioperative complications with new oral anticoagulants dabigatran, apixaban, and rivaroxaban in Mohs micrographic surgery: A retrospective study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Dabigatran; Female; Humans; Male; Middle Aged; Mohs Surgery; Postoperative Complications; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban | 2017 |
Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clinical Decision-Making; Dabigatran; Databases, Factual; Enoxaparin; Female; Fondaparinux; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Rivaroxaban; Venous Thrombosis; Warfarin | 2018 |
Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic Cancer.
Topics: Administration, Oral; Aged; Antithrombins; Dabigatran; Female; Humans; Male; Pancreatectomy; Pancreatic Neoplasms; Postoperative Complications; Treatment Outcome; Venous Thromboembolism | 2019 |
[The clotting tests and molecular markers in evaluating of coagulation alterations against the background of anti-thrombotic prevention by Dabigatran after large orthopedic operations].
Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinopeptide A; Humans; Knee Joint; Male; Middle Aged; Postoperative Complications; Thrombin; Venous Thrombosis | 2017 |
Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Confidence Intervals; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Follow-Up Studies; Humans; Intraoperative Care; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Perioperative Care; Postoperative Complications; Prospective Studies; Registries; Risk Assessment; Severity of Illness Index; Survival Rate; Thromboembolism; Thrombolytic Therapy; Treatment Outcome; Warfarin | 2013 |
Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Echocardiography, Transesophageal; Female; Humans; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Warfarin | 2013 |
A new oral anticoagulant in the setting of dermatologic surgery.
Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Dermatologic Surgical Procedures; Humans; Postoperative Complications; Thrombosis | 2013 |
Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
Topics: Adult; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Catheter Ablation; Comorbidity; Dabigatran; Embolism; Female; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Premedication; Retrospective Studies; Risk Assessment; Stroke; Tennessee; Treatment Outcome; Warfarin | 2013 |
Perioperative management of patients who are receiving a novel oral anticoagulant.
Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Male; Morpholines; Perioperative Care; Postoperative Complications; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Thromboembolism | 2013 |
Dabigatran and mechanical valves: less effective and more risky than warfarin.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Postoperative Complications; Thrombosis; Warfarin | 2013 |
Dabigatran for thromboprophylaxis after robotic assisted laparoscopic prostatectomy: retrospective analysis of safety profile and effect on blood coagulation.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Humans; Laparoscopy; Male; Middle Aged; Postoperative Complications; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Robotics; Thrombosis | 2014 |
Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Automation, Laboratory; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Equipment and Supplies; Factor VII; Hemorrhage; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Stroke; Thiophenes; Thrombelastography; Thrombin; Thrombin Time; Venous Thrombosis; Withholding Treatment | 2014 |
[Extrapolation of physiopathological data to clinical practice: Example of dabigatran in off-label use].
Topics: Administration, Oral; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Drug Substitution; Early Termination of Clinical Trials; Female; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Male; Middle Aged; Mitral Valve; Myocardial Infarction; Off-Label Use; Postoperative Complications; Pyridines; Randomized Controlled Trials as Topic; Stroke; Thromboembolism; Vitamin K | 2014 |
Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits.
Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Catheter Obstruction; Catheters; Dabigatran; Drug Dosage Calculations; Heart Valve Prosthesis Implantation; Heparin; Humans; In Vitro Techniques; Male; Models, Animal; Postoperative Complications; Rabbits; Thrombin; Thromboembolism; Thrombosis | 2014 |
Lessons from the RE-ALIGN trial.
Topics: Aged; Anticoagulants; Benzimidazoles; Bioprosthesis; Clinical Trials, Phase II as Topic; Dabigatran; Heart Valve Prosthesis; Hemorrhage; Humans; Myocardial Infarction; Postoperative Complications; Pyridines; Randomized Controlled Trials as Topic; Risk; Stroke; Thromboembolism; Warfarin | 2014 |
Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.
Topics: Administration, Oral; Aged; Algorithms; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Combined Modality Therapy; Dabigatran; Female; Heparin; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Radio Waves; Rivaroxaban; Thiophenes; Thromboembolism; Warfarin | 2014 |
A protruding lesion on the previous pulmonary vein isolation line in a case with paroxysmal atrial fibrillation.
Topics: Aged; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Echocardiography, Transesophageal; Female; Humans; Postoperative Complications; Pulmonary Veins; Thrombosis; Treatment Failure | 2015 |
Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin.
Topics: Administration, Oral; Aged; Anticoagulants; Dabigatran; Defibrillators, Implantable; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thromboembolism; Treatment Outcome; Warfarin | 2015 |
Opportunities for improvement: anticoagulation in patients undergoing total knee or hip replacement.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Dabigatran; Denmark; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Postoperative Complications; Quality Improvement; Registries; Retrospective Studies; Risk Assessment; Rivaroxaban; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Venous Thromboembolism | 2015 |
Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.
Topics: Action Potentials; Administration, Oral; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Drug Administration Schedule; Electrophysiologic Techniques, Cardiac; Factor Xa Inhibitors; Female; Heart Rate; Humans; Male; Middle Aged; Phenprocoumon; Postoperative Complications; Pyrazoles; Pyridones; Registries; Rivaroxaban; Stroke; Time Factors; Treatment Outcome | 2016 |
Data on procedural handling and complications of pulmonary vein isolation using the pulmonary vein ablation catheter GOLD®.
Topics: Aged; Antithrombins; Atrial Fibrillation; Catheter Ablation; Dabigatran; Databases, Factual; Electrodes, Implanted; Equipment Design; Europe; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Ischemic Attack, Transient; Male; Middle Aged; Postoperative Complications; Pulmonary Veins; Retrospective Studies; Rivaroxaban; Treatment Outcome | 2016 |
Dental implant surgery in patients in treatment by dabigatran.
Topics: Aged; Antithrombins; Case-Control Studies; Dabigatran; Dental Implantation, Endosseous; Female; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications | 2018 |
The Total Incidence of Complications and the Impact of an Anticoagulation Regime on Adverse Events After Cryoballoon Ablation of Atrial Fibrillation: A Single-Center Study of 409 Patients.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Biomarkers; Cryosurgery; Dabigatran; Female; Germany; Humans; Incidence; Inflammation Mediators; Male; Middle Aged; Phenprocoumon; Postoperative Complications; Pulmonary Veins; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Treatment Outcome | 2016 |
Silent Cerebral Ischemic Lesions After Catheter Ablation of Atrial Fibrillation in Patients on 5 Types of Periprocedural Oral Anticoagulation - Predictors of Diffusion-Weighted Imaging-Positive Lesions and Follow-up Magnetic Resonance Imaging.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain Infarction; Catheter Ablation; Dabigatran; Diffusion Magnetic Resonance Imaging; Follow-Up Studies; Humans; Male; Middle Aged; Perioperative Care; Postoperative Complications; Retrospective Studies | 2016 |
Comparative study of hemorrhagic and ischemic complications among anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Brain; Brain Ischemia; Cryosurgery; Dabigatran; Embolism; Female; Hemorrhage; Humans; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Warfarin | 2017 |
[Substantiation of the system of thrombus formation prevention in treatment of patients with hip joint pathology against the background of arterial insufficiency of the lower extremities].
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Arthroplasty, Replacement, Hip; Blood Coagulation; Dabigatran; Enoxaparin; Female; Humans; Lower Extremity; Male; Middle Aged; Osteoarthritis, Hip; Perioperative Care; Postoperative Complications; Retrospective Studies; Risk Adjustment; Russia; Thrombosis | 2016 |
A cost-utility analysis of dabigatran, enoxaparin, and usual care for venous thromboprophylaxis after hip or knee replacement surgery in Thailand.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Cost-Benefit Analysis; Dabigatran; Decision Trees; Enoxaparin; Health Care Costs; Humans; Monte Carlo Method; Postoperative Complications; Premedication; Quality-Adjusted Life Years; Thailand; Venous Thromboembolism | 2017 |
The novel anticoagulants: entering a new era.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Thromboembolism; Thrombolytic Therapy; Vitamin K | 2009 |
Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.
Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Elective Surgical Procedures; Humans; Morpholines; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2010 |
[The implication of a direct antithrombine in the appearance of (serious) postoperative acute respiratory distress].
Topics: Acute Disease; Aged; Anticoagulants; Antithrombins; Benzimidazoles; Dabigatran; Humans; Male; Postoperative Complications; Pyridines; Respiratory Distress Syndrome; Severity of Illness Index | 2009 |
Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacement.
Topics: Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Cost-Benefit Analysis; Dabigatran; Enoxaparin; Health Care Costs; Hemorrhage; Humans; Kidney Diseases; Postoperative Complications; Pyridines; United Kingdom; Venous Thromboembolism | 2010 |
New agents for orthopaedic thromboprophylaxis: caution essential, but time will tell.
Topics: Anticoagulants; Benzimidazoles; Dabigatran; Enoxaparin; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pyridines; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2009 |
[Cost-effectiveness analysis of methods for thromboprophylaxis after orthopedic surgery].
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Cost-Benefit Analysis; Dabigatran; Enoxaparin; Female; Health Care Costs; Humans; Male; Postoperative Complications; Pyridines; Thromboembolism; Treatment Outcome | 2010 |
Dabigatran offers the simplest solution for thromboprophylaxis after orthopaedic surgery in patients allergic to low-molecular-weight heparins.
Topics: Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Drug Eruptions; Female; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Pyridines; Venous Thrombosis | 2010 |
Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.
Topics: Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Clinical Trials as Topic; Cost-Benefit Analysis; Dabigatran; Enoxaparin; Fondaparinux; Heparin, Low-Molecular-Weight; Humans; Models, Economic; Morpholines; Polysaccharides; Postoperative Complications; Pyridines; Quality-Adjusted Life Years; Rivaroxaban; Thiophenes; Treatment Outcome; Venous Thromboembolism | 2010 |
[Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate].
Topics: Anticoagulants; Antithrombins; Benzimidazoles; Contraindications; Dabigatran; Drug Interactions; Heparin; Hirudin Therapy; Hirudins; Humans; Orthopedic Procedures; Peptide Fragments; Postoperative Complications; Pyridines; Recombinant Proteins; Thrombocytopenia; Thrombosis; Venous Thrombosis | 2011 |
New insights on the role of direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery.
Topics: Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Humans; Postoperative Complications; Randomized Controlled Trials as Topic; Venous Thromboembolism; Venous Thrombosis | 2011 |
An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Female; Health Care Costs; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Risk; Risk Factors; Rivaroxaban; Thiophenes; Venous Thromboembolism | 2011 |
Thrombolysis treatment for acute ischaemic stroke in a patient on treatment with dabigatran.
Topics: Aged; Antithrombins; Aphasia; Benzimidazoles; beta-Alanine; Carotid Artery Diseases; Dabigatran; Female; Fracture Fixation; Hemiplegia; Hemorrhage; Humans; Ischemia; Postoperative Complications; Practice Guidelines as Topic; Prosthesis Failure; Risk; Stroke; Thrombolytic Therapy; Thrombosis | 2011 |
Periprocedural management of patients on dabigatran etexilate treatment.
Topics: Antithrombin Proteins; Benzimidazoles; Contraindications; Dabigatran; Hemorrhage; Humans; Neurosurgical Procedures; Perioperative Care; Postoperative Complications; Pyridines | 2011 |
Thrombosis on a Mechanical Aortic Valve whilst Anti-coagulated With Dabigatran.
Topics: Aortic Valve; Aortic Valve Stenosis; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Drug Resistance; Echocardiography, Transesophageal; Fibrinolytic Agents; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Humans; Intracranial Embolism; Male; Middle Aged; Postoperative Complications; Risk Adjustment; Severity of Illness Index; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
[Pharmacologic heterogeneity of new anticoagulants].
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Drug Approval; Humans; Kidney; Liver; Morpholines; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; United States; United States Food and Drug Administration | 2011 |
Pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects after oral administration of dabigatran etexilate.
Topics: Administration, Oral; Adult; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Asian People; Atrial Fibrillation; Benzimidazoles; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dabigatran; Female; Humans; Male; Postoperative Complications; Pyridines; Thrombosis; White People | 2012 |
Anticoagulation prophylaxis in orthopedic surgery: an efficiency frontier approach.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Decision Trees; Drug Costs; Elective Surgical Procedures; Enoxaparin; Female; Humans; Male; Markov Chains; Models, Economic; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Quality-Adjusted Life Years; Rivaroxaban; State Medicine; Thiophenes; United Kingdom; Venous Thromboembolism | 2012 |
New directions in anticoagulation.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Warfarin | 2012 |
Oral thromboprophylaxis following total hip replacement: the issue of compliance.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antithrombin Proteins; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Medication Adherence; Middle Aged; Postoperative Complications; Prospective Studies; Pyridines; Treatment Outcome; Ultrasonography, Doppler; Venous Thromboembolism; Young Adult | 2012 |
Economic evaluation of dabigatran etexilate for the primary prevention of venous tromboembolic events following major orthopedic surgery in the Netherlands.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Benzimidazoles; Cohort Studies; Cost-Benefit Analysis; Dabigatran; Female; Fibrinolytic Agents; Humans; Infusions, Subcutaneous; Male; Middle Aged; Netherlands; Orthopedics; Postoperative Complications; Primary Prevention; Pyridines; Retrospective Studies; Venous Thromboembolism | 2012 |
Prescribing trends for dabigatran etexilate in primary care.
Topics: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Ireland; Male; Off-Label Use; Postoperative Complications; Practice Patterns, Physicians'; Primary Health Care; Retrospective Studies; Stroke; Venous Thromboembolism | 2012 |
Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis.
Topics: Aged; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Body Mass Index; Clinical Trials, Phase III as Topic; Dabigatran; Female; Humans; Male; Middle Aged; Obesity; Postoperative Complications; Risk Factors; Treatment Outcome; Venous Thromboembolism | 2012 |
A comparison of bleeding complications post-ablation between warfarin and dabigatran.
Topics: Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Stroke; Treatment Outcome; Warfarin | 2012 |
New ESC guidelines on atrial fibrillation accept reality of next generation of anti-coagulants.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Europe; Humans; Postoperative Complications; Practice Guidelines as Topic; United States; Vascular Surgical Procedures; Venous Thromboembolism; Warfarin | 2012 |
New oral anticoagulants.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Canada; Contraindications; Dabigatran; Drug Dosage Calculations; Drug Interactions; Humans; Morpholines; Postoperative Complications; Pyridines; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis | 2013 |
Dabigatran vs. low molecular weight heparin in preventing venous thromboembolism after elective hip and knee arthroplasty: evaluation of selected clinical parameters.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Postoperative Complications; Pyridines; Randomized Controlled Trials as Topic; Venous Thromboembolism; Venous Thrombosis | 2012 |
Trials of venous thromboembolism prevention.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Enoxaparin; Humans; Postoperative Complications; Pyridines; Randomized Controlled Trials as Topic; Reproducibility of Results; Venous Thrombosis | 2007 |
Dabigatran versus enoxaparin after total hip replacement.
Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; Cost-Benefit Analysis; Dabigatran; Enoxaparin; Humans; Phlebography; Postoperative Complications; Pyridines; Venous Thromboembolism | 2007 |
[Oral anticoagulation after major hip or knee replacement surgery: a process-driven managerial pharmacoeconomic analysis in German hospitals].
Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Economics, Pharmaceutical; Germany; Health Care Costs; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Pyridines; Retrospective Studies; Treatment Outcome; Venous Thromboembolism | 2008 |